An Exploratory Study to Establish the Dose, Safety and Pathogenicity of a SARS-CoV-2 Omicron Challenge Strain (BA.5) in Healthy Participants 18 to 30 Years of Age

An Exploratory Study to Establish the Dose, Safety and Pathogenicity of a SARS-CoV-2 Omicron Challenge Strain (BA.5) in Healthy Participants 18 to 30 Years of Age

Publication date: Jul 05, 2024

An Exploratory Study to Establish the Dose, Safety and Pathogenicity of a SARS-CoV-2 Omicron Challenge Strain (BA. 5) in Healthy Participants 18 to 30 Years of Age

Concepts Keywords
30kg COVID-19
Breastfeeding Human Challenge Trials
Outpatient Omicron
Viral SARS-CoV-2
Vitamins

Semantics

Type Source Name
disease VO dose
disease VO age
disease IDO history
disease MESH abnormalities
disease VO vaccinated
disease VO COVID-19 vaccine
disease MESH infection
disease VO time
disease MESH anaphylaxis
disease MESH allergic reaction
disease MESH COVID-19
disease MESH viral disease
disease VO nose
disease MESH nasal polyps
disease MESH epistaxis
disease VO vaccination
disease IDO blood
disease VO Viruses
pathway REACTOME Vitamins
disease MESH alcohol
drug DRUGBANK Ethanol
disease VO volume

Original Article

(Visited 3 times, 1 visits today)